Class III · Lower riskActive recall
Glycopyrrolate
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Where it was soldUS Nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurities/Degradation Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byMSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854
| Brand name | GLYCOPYRROLATE |
| Generic name | GLYCOPYRROLATE |
| Active ingredient(s) | GLYCOPYRROLATE |
| Distributed by / for | Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854 |
| NDC | 72205-070-72 |
Show the full FDA record
| Full product label | Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 |
| Recalling firm | NOVADOZ PHARMACEUTICALS LLC |
| Distribution | US Nationwide. |
| Quantity | N/A |
| Recall initiated | 2025-12-15 |
| Report date | 2026-02-04 |
| Recall completed | — |
| Recall number | D-0300-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Piscataway NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.